Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Antihelminthics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Antihelminthics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Benzimidazoles
      • 1.3.3 Abamectin
      • 1.3.4 Salicylanilides
      • 1.3.5 Praziquantel
      • 1.3.6 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Antihelminthics Market Share by Application (2019-2025)
      • 1.4.2 Schistosomiasis
      • 1.4.3 Fasciolasis
      • 1.4.4 Filariasis
      • 1.4.5 Angiostrongylosis
      • 1.4.6 Ascariasis
      • 1.4.7 Giardiasis
      • 1.4.8 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Antihelminthics Market Size
      • 2.1.1 Global Antihelminthics Revenue 2014-2025
      • 2.1.2 Global Antihelminthics Sales 2014-2025
    • 2.2 Antihelminthics Growth Rate by Regions
      • 2.2.1 Global Antihelminthics Sales by Regions 2014-2019
      • 2.2.2 Global Antihelminthics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Antihelminthics Sales by Manufacturers
      • 3.1.1 Antihelminthics Sales by Manufacturers 2014-2019
      • 3.1.2 Antihelminthics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Antihelminthics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antihelminthics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Antihelminthics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Antihelminthics Price by Manufacturers
    • 3.4 Key Manufacturers Antihelminthics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Antihelminthics Market
    • 3.6 Key Manufacturers Antihelminthics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Benzimidazoles Sales and Revenue (2014-2019)
      • 4.1.2 Abamectin Sales and Revenue (2014-2019)
      • 4.1.3 Salicylanilides Sales and Revenue (2014-2019)
      • 4.1.4 Praziquantel Sales and Revenue (2014-2019)
      • 4.1.5 Other Sales and Revenue (2014-2019)
    • 4.2 Global Antihelminthics Sales Market Share by Type
    • 4.3 Global Antihelminthics Revenue Market Share by Type
    • 4.4 Antihelminthics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Antihelminthics Sales by Application

    6 United States

    • 6.1 United States Antihelminthics Breakdown Data by Company
    • 6.2 United States Antihelminthics Breakdown Data by Type
    • 6.3 United States Antihelminthics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Antihelminthics Breakdown Data by Company
    • 7.2 European Union Antihelminthics Breakdown Data by Type
    • 7.3 European Union Antihelminthics Breakdown Data by Application

    8 China

    • 8.1 China Antihelminthics Breakdown Data by Company
    • 8.2 China Antihelminthics Breakdown Data by Type
    • 8.3 China Antihelminthics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Antihelminthics Breakdown Data by Company
    • 9.2 Rest of World Antihelminthics Breakdown Data by Type
    • 9.3 Rest of World Antihelminthics Breakdown Data by Application
    • 9.4 Rest of World Antihelminthics Breakdown Data by Countries
      • 9.4.1 Rest of World Antihelminthics Sales by Countries
      • 9.4.2 Rest of World Antihelminthics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Abbott
      • 10.1.1 Abbott Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.1.4 Antihelminthics Product Introduction
      • 10.1.5 Abbott Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.2.4 Antihelminthics Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 ZEISS International
      • 10.3.1 ZEISS International Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.3.4 Antihelminthics Product Introduction
      • 10.3.5 ZEISS International Recent Development
    • 10.4 Johnson & Johnson
      • 10.4.1 Johnson & Johnson Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.4.4 Antihelminthics Product Introduction
      • 10.4.5 Johnson & Johnson Recent Development
    • 10.5 Sanofi
      • 10.5.1 Sanofi Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.5.4 Antihelminthics Product Introduction
      • 10.5.5 Sanofi Recent Development
    • 10.6 Merck & Co.
      • 10.6.1 Merck & Co. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.6.4 Antihelminthics Product Introduction
      • 10.6.5 Merck & Co. Recent Development
    • 10.7 GlaxoSmithKline
      • 10.7.1 GlaxoSmithKline Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.7.4 Antihelminthics Product Introduction
      • 10.7.5 GlaxoSmithKline Recent Development
    • 10.8 Astellas Pharma
      • 10.8.1 Astellas Pharma Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.8.4 Antihelminthics Product Introduction
      • 10.8.5 Astellas Pharma Recent Development
    • 10.9 Bayer
      • 10.9.1 Bayer Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.9.4 Antihelminthics Product Introduction
      • 10.9.5 Bayer Recent Development
    • 10.10 Mentis Pharma
      • 10.10.1 Mentis Pharma Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Antihelminthics
      • 10.10.4 Antihelminthics Product Introduction
      • 10.10.5 Mentis Pharma Recent Development
    • 10.11 Pfizer
    • 10.12 Sanofi
    • 10.13 ALLERGAN
    • 10.14 AstraZeneca

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Antihelminthics Sales Channels
      • 11.2.2 Antihelminthics Distributors
    • 11.3 Antihelminthics Customers

    12 Market Forecast

    • 12.1 Global Antihelminthics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Antihelminthics Sales Forecast by Type
    • 12.3 Global Antihelminthics Sales Forecast by Application
    • 12.4 Antihelminthics Forecast by Regions
      • 12.4.1 Global Antihelminthics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Antihelminthics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host.
      In 2019, the market size of Antihelminthics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antihelminthics.

      This report studies the global market size of Antihelminthics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Antihelminthics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott
      Novartis
      ZEISS International
      Johnson & Johnson
      Sanofi
      Merck & Co.
      GlaxoSmithKline
      Astellas Pharma
      Bayer
      Mentis Pharma
      Pfizer
      Sanofi
      ALLERGAN
      AstraZeneca

      Market Segment by Product Type
      Benzimidazoles
      Abamectin
      Salicylanilides
      Praziquantel
      Other

      Market Segment by Application
      Schistosomiasis
      Fasciolasis
      Filariasis
      Angiostrongylosis
      Ascariasis
      Giardiasis
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Antihelminthics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Antihelminthics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Antihelminthics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now